Journal History

2009 The inaugural issue was released. Cancers was published as a quarterly journal.
2013 Cancers was indexed in PubMed (NLM) and Scopus.
2015 Cancers changed to publish in article number order instead of in page range order.
2016 Cancers adopted a monthly publication schedule.
Cancers announced the first edition of the Travel Awards.
The journal Twitter account was established.
2017 Cancers was indexed in Science Citation Index Expanded (SCIE)—Web of Science (Clarivate Analytics).
2018 Cancers received its first Impact Factor (5.326), ranked 44/222 (Q1) in "Oncology".
2019 Cancers received its 2018 Impact Factor (6.162), ranked 31/229 (Q1) in "Oncology" in JCR.
Signal Transduction Society (STS) became affiliated to Cancers.
2020 Cancers established the following sections:
- Molecular Cancer Biology;
- Cancer Immunology and Immunotherapy;
- Cancer Biomarkers;
- Cancer Epidemiology and Prevention;
- Cancer Pathophysiology;
- Tumor Microenvironment;
- Cancer Causes, Screening and Diagnosis;
- Cancer Nursing and Care;
- Cancer Therapy;
- Clinical Trials of Cancer;
- Systematic Review or Meta-Analysis in Cancer Research;
- Methods and Technologies Development;
- Cancer Informatics and Big Data.
Cancers announced the first edition of the Outstanding Reviewer Awards and second edition of the Young Investigator Awards.
Cancers published its 5,000th paper.
2021 Cancers adopted a semi-monthly publication schedule.
Cancers received its 2020 Impact Factor (6.639), ranked 51/242 (Q1) in "Oncology".
Cancers published its 10,000th paper.
Cancers established the following sections:
- Pediatric Oncology;
- Infectious Agents and Cancer.

- Cancer Nursing and Care was renamed as Transplant Oncology and Cancer Nursing Care.
Cancers received its 2021 Impact Factor (6.575), ranked 60/245 (Q1) in "Oncology".
Cancers established the following sections:
- Cancer Drug Development;
- Cancer Metastasis.


Cancers received its 2022 Impact Factor (5.2), ranked 72/241 (Q2) in "Oncology".
Transplant Oncology and Cancer Nursing Care was divided as the following sections:
Transplant Oncology;
Cancer Survivorship and Quality of Life.
Clinical Trials of Cancer was renamed as Clinical Research of Cancer.


2009–2015 Editor-in-Chief: Prof. Dr. Robert H. Weiss
2015–present Editor-in-Chief: Prof. Dr. Samuel C. Mok

Section Editor-in-Chief

2020–2022 Section Editor-in-Chief: Prof. Dr. Eduardo Nagore for the section on Cancer Epidemiology and Prevention
2020–present Section Editor-in-Chief: Dr. Carlos S. Moreno for the section on Cancer Biomarkers
Section Editor-in-Chief:
Prof. Dr. Donat Kögel for the section on Molecular Cancer Biology
Section Editor-in-Chief:
Dr. Barbara Wegiel for the section on Cancer Immunology and Immunotherapy
Section Editor-in-Chief:
Dr. Nicola Amodio for the section on Cancer Pathophysiology
Section Editor-in-Chief:
Prof. Dr. Sanjay Gupta for the section on Tumor Microenvironment
Section Editor-in-Chief:
Dr. Kevin Camphausen for the section on Cancer Therapy
Section Editor-in-Chief:
Prof. Dr. Alexandre Escargueil for the section on Cancer Therapy
Section Editor-in-Chief:
Prof. Dr. Massimo Di Maio for the section on Systematic Review or Meta-Analysis in Cancer Research
Section Editor-in-Chief:
Dr. Jason Roszik for the section on Cancer Informatics and Big Data
Section Editor-in-Chief:
Prof. Dr. Massoud Mirshahi for the section on Cancer Causes, Screening and Diagnosis
2021–2022 Section Editor-in-Chief: Prof. Dr. Antoine Italiano for the section on Clinical Trials of Cancer
2022–2023 Section Editor-in-Chief: Dr. Maen Abdelrahim for the section on Transplant Oncology and Cancer Nursing Care
2020–2023 Section Editor-in-Chief: Prof. Dr. Fiona Lyng for the section on Methods and Technologies Development
2022–present Section Editor-in-Chief: Dr. Sam Mbulaiteye for the section on Infectious Agents and Cancer
Section Editor-in-Chief: 
Prof. Dr. Anupam Bishayee for the section on Cancer Drug Development
Section Editor-in-Chief: 
Prof. Dr. Sanjay K. Srivastava for the section on Cancer Metastasis

Section Editor-in-Chief: Dr. Maen Abdelrahim for the section on Transplant Oncology
Section Editor-in-Chief: Prof. Dr. Naoto T. Ueno for the section on Clinical Research of Cancer


Section Editor-in-Chief: Prof. Dr. Sebastiano Mercadante for the section on Cancer Survivorship and Quality of Life

Back to TopTop